[IrvineFriend]

Dr. Google did a good job. As we all know, Trastuzumab and Pertuzumab can stop working for HER2+ cancer. So this is a completely different mechanism that will be another choice for patients who have failed on the current standard of care. I'll be in S. Korea the week of June 1st. And I don't consider this is a last ditch effort, it's just easier to get a product approved or a trial approved when you're not proving superiority to existing products. It's just going to be another option. I can't disclose any details until results are published but hoping to start a Phase 2 trial in the US before end of the year. Other companies are doing great work too.